Inflammation in obesity, diabetes, and related disorders
Obesity leads to chronic, systemic inflammation and can lead to insulin resistance (IR), β-cell
dysfunction, and ultimately type 2 diabetes (T2D). This chronic inflammatory state …
dysfunction, and ultimately type 2 diabetes (T2D). This chronic inflammatory state …
Myocardial ischemia-reperfusion injury and the influence of inflammation
Acute myocardial infarction is caused by a sudden coronary artery occlusion and leads to
ischemia in the corresponding myocardial territory which generally results in myocardial …
ischemia in the corresponding myocardial territory which generally results in myocardial …
Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease
The intracellular sensing protein termed NLRP3 (for NACHT, LRR, and PYD domains-
containing protein 3) forms a macromolecular structure called the NLRP3 inflammasome …
containing protein 3) forms a macromolecular structure called the NLRP3 inflammasome …
Targeting innate immune mediators in type 1 and type 2 diabetes
MY Donath, CA Dinarello… - Nature Reviews …, 2019 - nature.com
Type 1 and type 2 diabetes are characterized by chronic inflammation; both diseases
involve pancreatic islet inflammation, while systemic low-grade inflammation is a feature of …
involve pancreatic islet inflammation, while systemic low-grade inflammation is a feature of …
Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease
L Liberale, F Montecucco, JC Tardif… - European heart …, 2020 - academic.oup.com
The ongoing worldwide increase in life expectancy portends a rising prevalence of age-
related cardiovascular (CV) diseases in the coming decades that demands a deeper …
related cardiovascular (CV) diseases in the coming decades that demands a deeper …
Management of myocarditis-related cardiomyopathy in adults
Myocarditis is generally a mild and self-limited consequence of systemic infection of
cardiotropic viruses. However, patients can develop a temporary or permanent impairment …
cardiotropic viruses. However, patients can develop a temporary or permanent impairment …
Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction
Background ST‐segment–elevation myocardial infarction is associated with an intense
acute inflammatory response and risk of heart failure. We tested whether interleukin‐1 …
acute inflammatory response and risk of heart failure. We tested whether interleukin‐1 …
Targeting residual inflammatory risk: a shifting paradigm for atherosclerotic disease
As biologic, epidemiologic, and clinical trial data have demonstrated, inflammation is a key
driver of atherosclerosis. Circulating biomarkers of inflammation, including high-sensitivity C …
driver of atherosclerosis. Circulating biomarkers of inflammation, including high-sensitivity C …
NLRP3 inflammasome: The rising star in cardiovascular diseases
Y Zheng, L Xu, N Dong, F Li - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Cardiovascular diseases (CVDs) are the prevalent cause of mortality around the world.
Activation of inflammasome contributes to the pathological progression of cardiovascular …
Activation of inflammasome contributes to the pathological progression of cardiovascular …
Update on heart failure management and future directions
HM Choi, MS Park, JC Youn - The Korean journal of internal …, 2018 - pmc.ncbi.nlm.nih.gov
Heart failure (HF) is an important cardiovascular disease because of its increasing
prevalence, significant morbidity, high mortality, and rapidly expanding health care cost. The …
prevalence, significant morbidity, high mortality, and rapidly expanding health care cost. The …